SIM
VYNT

SSI Investment Management’s Vyant Bio, Inc. Common Stock VYNT Stock Holding History

SSI Investment Management’s Portfolio VYNT Stock Details VYNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-434
Closed -$434K – 358
2014
Q4 		$434K Buy
434
+4
+0.9% +$4.01K 0.04% 237
2014
Q3 		$581K Buy
430
+283
+193% +$405K 0.06% 207
2014
Q2 		$249K Sell
147
-9
-6% -$17.1K 0.02% 346
2014
Q1 		$352K Sell
156
-264
-63% -$676K 0.04% 298
2013
Q4 		$868K Buy
+420
New +$907K 0.08% 237

Other funds holding VYNT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MAG
Millrace Asset Group Berwyn, Pennsylvania $98.4M AUM 63.71% 1-Year Est. Return
GIP
Granite Investment Partners El Segundo, California $1.95B AUM 49.89% 1-Year Est. Return
TI
Turner Investments Berwyn, Pennsylvania $134K AUM 49.03% 1-Year Est. Return
GMCM
Gruber & McBaine Capital Management San Francisco, California $369M AUM 12.23% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
SCM
Sterneck Capital Management Kansas City, Missouri $233M AUM 21.98% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

SSI Investment Management's VYNT Position: Q1 2015 in Review

SSI Investment Management sold out of Vyant Bio, Inc. Common Stock (VYNT) in Q1 2015, closing a stake of 434 shares — an estimated $434K sold.

SSI Investment Management first reported a position in VYNT in Q4 2013 and held it in 5 quarters. The position peaked at $868K in Q4 2013. 29 funds tracked by Wall St. Rank hold VYNT as of Q1 2015.

  • SSI Investment Management reported no remaining Vyant Bio, Inc. Common Stock position as of Q1 2015 after selling out during the quarter.
  • SSI Investment Management sold 434 Vyant Bio, Inc. Common Stock shares in Q1 2015, an estimated $434K.
  • SSI Investment Management first reported a position in Vyant Bio, Inc. Common Stock in Q4 2013 and held it in 5 quarters.
  • SSI Investment Management's Vyant Bio, Inc. Common Stock position peaked at $868K in Q4 2013.
  • 29 funds tracked by Wall St. Rank held Vyant Bio, Inc. Common Stock as of Q1 2015.

Based on SSI Investment Management's 13F filing for Q1 2015, filed 12 May 2015.